Evidence map›Paper›PMID 32664225›Full record

ArticleBiomolecules2020

The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension.

Michał Biernacki, Marta Baranowska-Kuczko, Gabriella N Niklińska, Elżbieta Skrzydlewska

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michał BiernackiDepartment of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.ORCID 0000-0001-9101-5125
Marta Baranowska-KuczkoDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Mickiewicza 2A, 15-222 Bialystok, Poland.
Gabriella N NiklińskaDepartment of Large Animal Diseases and Clinic, Institute of Veterinary Research Centre and Center for Biomedical Research, Warsaw University of Life Science, 100 Nowoursynowska St., 02-797 Warsaw, Poland.
Elżbieta SkrzydlewskaDepartment of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.ORCID 0000-0001-5397-7139
Medical University of Białystok · PLWarsaw University of Life Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is accompanied by oxidative stress, which can be modified by the functioning of the endocannabinoid system playing a prominent modulatory role in the brain. The present study tested whether chronic administration of the fatty acid amide hydrolase (FAAH) inhibitor [3-(3-carbamoylphenyl) phenyl]N-cyclohexylcarbamate (URB597) to rats with primary hypertension (SHR) can modify redox balance and consequently brain phospholipid metabolism. Experiments were conducted using SHRs and normotensive control Wistar-Kyoto rats treated by intraperitoneal injection with URB597 for 14 days. The biochemical parameters were assayed in the rats' brains. Inhibition of FAAH activity by URB597 resulted in an increase in anandamide and GPR55 receptor levels, as well as a decrease in CB

Indexed as

AnimalsArachidonic AcidsBenzamidesBrainCarbamatesDisease Models, AnimalEndocannabinoidsHypertensionInjections, IntraperitonealMaleMalondialdehydeOxidation-ReductionPhospholipidsPolyunsaturated AlkamidesRatsRats, Inbred SHRanandamideArachidonic AcidsBenzamidesCarbamatesCnr2 protein, ratcyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterEndocannabinoidsGPR55 protein, ratMalondialdehydePhospholipidsPolyunsaturated AlkamidesReceptor, Cannabinoid, CB2Receptors, CannabinoidReceptors, G-Protein-Coupledendocannabinoid systemlipid peroxidation productsrat brainspontaneous hypertensionURB597

Identifiers

PMID32664225
PMCPMC7407381
OpenAlexW3040748049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.